pharmaphorum

AUGUST 11, 2022

More than 60 percent of all American adults take prescription drugs , amounting to approximately 131 million individuals. This means that hyper-metabolisers would need their dosage to be increased to achieve the desired effect. billion in the United States alone.

Side effects 86

Side effects Medical Prescription Patients 86

Legacy MEDSearch

OCTOBER 25, 2023

Theranica , a neuromodulation therapeutics company, announced the publication of a comprehensive clinical study in Advances in Therapy examining the long-term utilization, clinical efficacy, and safety of Nerivio ® , a Remote Electrical Neuromodulation (REN) device for the treatment of migraine.

Side effects 52

Side effects Recruitment Networking Management 52

Pharmaceutical Technology

JUNE 1, 2023

For context, in January 2023, the FDA accepted Intercept’s resubmission of its NDA for OCA as a Class 2 resubmission (which has a six-month review period in NASH) and set a Prescription Drug User Fee Act (PDUFA) date of 22 June 2023. risk reduction compared with placebo).

FDA 52

FDA Side effects Prescription Patients 52

PM360

SEPTEMBER 21, 2023

With more than 10 generics set to enter the market in 2023, costs are again expected to come down quickly. This could actually have double importance because of the drug shortages going on in ADHD market,” Casberg said of the generic launch. This product would be a more potent prescription version than the OTCs, Casberg notes.

Management 105

Management Manufacturing Sales Competition 105

PM360

OCTOBER 13, 2023

Doctor Docs: Targeting Trust Between Pharma and HCPs A new study shows the crucial link in pharma marketers’ digital engagement strategy with HCPs is in jeopardy—trust. Pharma marketers can look into these concerns to better tailor digital content and platforms to provide HCPs with what they need to make unbiased and informed decisions.

Healthcare 59

Healthcare Healthcare Doctors Pharma 59

PM360

JULY 13, 2023

BrightInsight PSP+ Companion App BrightInsight Jamie Burgess, Senior Vice President, Marketing jamie.burgess@brightinsight.com Patient support programs (PSPs) are a proven way to smooth the patient journey, speed time to fill, and improve conversion. But outdated manual processes are complex and leave many patients out. 1 References: 1.

Education 89

Education Medical Media Patients 89

PM360

JUNE 11, 2022

To help pharma to form better working relationships with patients, we asked patients who have experience working with the industry, pharma marketers who have partnered with patients, and agencies and other companies who specialize in patient engagement to tell us: What do you look for in a partnership with a pharma company/patient?

Patients 59

Patients Pharma Education Media 59

Medgadget

MAY 2, 2023

These treatments at times come with a long list of side effects, leaving many patients in search of an effective long-term solution. For some patients with PTSD, psychotherapy may not be an effective option, they may find talking about their traumatic experience stress inducing, untherapeutic or ineffective.

Side effects 87

Side effects Prescription Healthcare Healthcare 87

PM360

SEPTEMBER 15, 2022

To me, “patient centricity” evokes an old-school market research lab where patients were asked to choose between options that often had little to do with what mattered most to them, while we watched behind two-way mirrors. Yet despite earnest efforts and meaningful progress, the “patient-first” concept still feels aspirational.

Patients 98

Patients Education Management Side effects 98

Pharmaceutical Technology

OCTOBER 10, 2022

Despite the recognized need and demand for options to treat female sexual dysfunction, several safety and access issues associated with the use of available options. Moreover, despite the buzz generated when Addyi was launched in 2015, only one other drug has since been marketed. A one-size-fits-all approach.

Pharmacology 59

Pharmacology Side effects FDA Safety 59

Pharmaceutical Technology

MAY 31, 2023

The US Food and Drug Administration (FDA) has proposed a new model for prescription medication guides for brand name and generic drugs, to increase accessibility and reduce medication nonadherence. The agency describes the current system as “confusing, conflicting, incomplete, or repetitive”, based on study data.

Prescription 52

Prescription FDA Food and Drug Administration Medical 52